Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Mahmoud A Elshenawy"'
Autor:
Hisham Alquaydheb, Abrar Alharbi, Ahmed Badran, Bader Alshamsan, Ghada Algwaiz, Mahmoud A Elshenawy, Dahish Ajarim
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 16 (2023)
SARS-CoV-2 infection induces myocardiopathy in 19% of severe cases, with a mortality rate of up to 51%. The mainstay of treatment is supportive care, steroids, and tocilizumab (anti-IL-6). This is a case of a 43-year-old woman diagnosed with hormone-
Externí odkaz:
https://doaj.org/article/9c172cb5089842babda82ce2a6df4b01
Autor:
Ahmed Badran, Saad Salman Ali, Tarek Ziad Arabi, Abdullaah Khaleel Hinkston, Abdullah Shaik, Mahmoud A Elshenawy, Dahish Ajarim
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 16 (2023)
Human epidermal growth factor receptor-positive breast cancer is an aggressive cancer which represents approximately a quarter of all breast cancers worldwide. Recent advances have led to the development of targeted therapies, such as trastuzumab (H)
Externí odkaz:
https://doaj.org/article/20370b27a9bf4f7085e2b7453d651670
Autor:
Ali Aljubran, Mahmoud A Elshenawy, Magdy Kandil, Muhammed N Zahir, Ahmed Shaheen, Ahmed Gad, Omar Alshaer, Ahmed Alzahrani, Abdelmonem Eldali, Shouki Bazarbashi
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 13 (2019)
Background: Regorafenib is a multi-kinase inhibitor approved for treatment of refractory advanced colorectal cancer. It was found in the clinical trials to have a modest benefit and significant toxicity. Our aim was to assess the outcome in our local
Externí odkaz:
https://doaj.org/article/4b9c91c1f783485a9cbe8fefc50da313
Autor:
Saad Akhtar, M. Shahzad Rauf, Yasser Khafaga, Amani Al-Kofide, Tusneem Ahmed M. Elhassan, Mahmoud A. Elshenawy, Juzer Nadri, Ali Hassan Mushtaq, Nasir Bakshi, Mohammed Shamayel, Suleiman Al-Sweedan, Sohail Sarwar, Irfan Maghfoor
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-16 (2021)
Abstract Background Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon variant of Hodgkin lymphoma. There is limited data on treatment, management of refractory and relapsed disease, and long-term outcome. Many registries or count
Externí odkaz:
https://doaj.org/article/a78336581c4c43abb99ae5846ececb2f
Autor:
Saad Akhtar, M. Shahzad Rauf, Amani Al-Kofide, Mahmoud A. Elshenawy, Ali Hassan Mushtaq, Irfan Maghfoor
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-6 (2021)
Abstract Background Familial clustering of lymphoid and/or hematological malignancies (FHM) provides an opportunity to study the responsible genes. The data is limited in patients with lymphoid and hematological malignancies. Methods The lymphoma dat
Externí odkaz:
https://doaj.org/article/47270aeab6174fa2b734238d4e4a5dec
Autor:
Saad Akhtar, M. Shahzad Rauf, Tusneem Ahmed M. Elhassan, Zubair Ali Khan, Mahmoud A. Elshenawy, Irfan Maghfoor
Publikováno v:
Transplantation and Cellular Therapy.
Autor:
Hagar A. Alagizy, Hayam Abdel-Samie Aiad, Moshira Mohamed Abdel-Wahed, Mahmoud Abdelsattar Elshenawy, Heba Gaber Abou-Sheishai, Hala Said El-Rebey
Publikováno v:
The Egyptian Journal of Hospital Medicine. 87:1216-1225
Autor:
Mahmoud Awad Elshenawy, Sobhy Mohamed Abdelkader, Abdelrahman Ahmed Amin, Soliman Ahmed Farghal
Publikováno v:
IET Smart Grid (2019)
The synchronverter (SV) is currently one of the most promising grid-friendly inverters that mimic synchronous generators (SGs). Almost all the available SV use virtual current signal for synchronization, which require a complicated controller that la
Externí odkaz:
https://doaj.org/article/61e76256e9a749e58a7eedfd0aafdc55
Autor:
Tusneem Elhassan, Aisha Alshibany, Jean Paul Atallah, Mahmoud A. Elshenawy, Ahmad Badran, Fatma Maraiki, Bader I Alshamsan
Publikováno v:
Cancer Management and Research
Bader Alshamsan, 1, 2 Ahmad Badran, 1, 3 Aisha Alshibany, 1 Fatma Maraiki, 1 Mahmoud A Elshenawy, 1, 4 Tusneem Elhassan, 1 Jean Paul Atallah 1 1Medical Oncology, Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arab
Autor:
Shouki Bazarbashi, Ahmed Badran, Ahmed Mostafa Gad, Ali Aljubran, Ahmed Alzahrani, Aisha Alshibani, Reem Alrakaf, Tusneem Elhassan, Abdullah Alsuhaibani, Mahmoud A. Elshenawy
Publikováno v:
Annals of surgical oncology. 30(1)